Compare TTEC & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTEC | ORMP |
|---|---|---|
| Founded | 1982 | 2002 |
| Country | United States | United States |
| Employees | 69400 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.5M | 134.1M |
| IPO Year | 1996 | 2010 |
| Metric | TTEC | ORMP |
|---|---|---|
| Price | $2.47 | $3.25 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 663.1K | 164.3K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.61% |
| EPS Growth | ★ 40.80 | N/A |
| EPS | N/A | ★ 1.26 |
| Revenue | ★ $1,509,171,000.00 | $1,340,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.61 |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $1.98 | $1.82 |
| 52 Week High | $5.60 | $3.76 |
| Indicator | TTEC | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 46.86 | 47.00 |
| Support Level | $2.05 | $3.22 |
| Resistance Level | $3.84 | $3.76 |
| Average True Range (ATR) | 0.22 | 0.21 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 53.23 | 22.22 |
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.